Fei Li

CapeOX Versus Capecitabine in Neoadjuvant Chemoradiatie for High-Risico Locally Gevorderd Rectal Cancer: Langetermijn Resultaten From MONT-R Gerandomiseerde Controlled Trial

Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Rela...

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patiënt...

A new treatment strategy for mid-low rectal cancer patients exhibiting a clinical complete or near-complete response ...

Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Gerandomiseerde Fase III RELARC Trial.

Golidocitinib (selectieve JAK1-remmer) bij refractair/recidief perifeer T-cellymfoom

Perioperatieve versus postoperatieve adjuvante oxaliplatine-S-1 bij maagcarcinoom: RESOLVE fase III

Complete mesocolische excisie versus D2-dissectie bij laparoscopisch coloncarcinoom